Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...

California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.

The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...

The state-branded, life-saving drugs for some 3.5 million Californians with diabetes will be much cheaper, the governor ...

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

The Trump administration has determined the U.S. is in a "non-international armed conflict" with drug cartels it has designated as terrorist organizations, it said in a notification to Congress viewed ...

WASHINGTON, Sept 29 (Reuters) - President Donald Trump's administration started detailing its plans on Monday for which services it will pause if the federal government shuts down this week, with the ...

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: ...

WASHINGTON — The White House unveiled its newly installed Presidential Hall of Fame on Wednesday, displaying the official portraits of all former presidents — with the exception of former President ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. U.S. Army AH-64E Apache helicopters are pictured ...